Product Information
ENTECAVIR 0.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.2117 per EA under NDC 69097042602. Its NADAC has been published 485 times since Mar 15, 2017.
Strength
.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097042602
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206872On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 0.5 MG TABLET has been published 485 times since Mar 15, 2017, and over the history we have for it it has declined 97.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2117 per EA |
|---|---|
| All-time high | $9.9327 (Apr 12, 2017) |
| All-time low | $0.2096 (May 20, 2026) |
| 52-week high | $0.2677 |
| 52-week low | $0.2096 |
| Median price | $1.0129 |
| Average price | $1.5678 |
| Largest weekly change | +48.1% (Jul 17, 2024) |
| Weeks tracked | 485 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENTECAVIR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Cipla USA Inc., is $0.2117 per EA (NDC 69097042602), effective Jun 24, 2026.
How has the price of ENTECAVIR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 97.6%. It has been tracked across 485 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?
Since Mar 15, 2017, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $9.9327 (Apr 12, 2017), with a median of $1.0129 per EA.
Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ENTECAVIR 0.5 MG TABLET, but none are currently priced below it.
Who manufactures ENTECAVIR 0.5 MG TABLET?
ENTECAVIR 0.5 MG TABLET (NDC 69097042602) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification